Biopharma companies are making record investments in C & GT. These novel technologies are also changing the way life science companies develop treatments and organize their businesses.
Biopharma companies are making record investments in C & GT. These novel technologies are also changing the way life science companies develop treatments and organize their businesses.
Biopharma companies pursuing CGTs are undergoing significant change. The way contract research, contract manufacturing and clinical research service providers sell into these companies is changing too.